|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1999-7-16
|
|
pubmed:abstractText |
There is no treatment proven to limit the growth of abdominal aortic aneurysms, in which the histological hallmarks include inflammation and medial atrophy, with apoptosis of smooth muscle cells and destruction of elastin.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents...,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL2,
http://linkedlifedata.com/resource/pubmed/chemical/Culture Media, Conditioned,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2 Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Dinoprostone,
http://linkedlifedata.com/resource/pubmed/chemical/Indomethacin,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/PTGS2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandin-Endoperoxide Synthases
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
6
|
|
pubmed:volume |
100
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
48-54
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10393680-Adolescent,
pubmed-meshheading:10393680-Aged,
pubmed-meshheading:10393680-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:10393680-Aortic Aneurysm, Abdominal,
pubmed-meshheading:10393680-Apoptosis,
pubmed-meshheading:10393680-Cell Division,
pubmed-meshheading:10393680-Cells, Cultured,
pubmed-meshheading:10393680-Chemokine CCL2,
pubmed-meshheading:10393680-Cohort Studies,
pubmed-meshheading:10393680-Culture Media, Conditioned,
pubmed-meshheading:10393680-Cyclooxygenase 2,
pubmed-meshheading:10393680-Cyclooxygenase 2 Inhibitors,
pubmed-meshheading:10393680-Cyclooxygenase Inhibitors,
pubmed-meshheading:10393680-DNA Replication,
pubmed-meshheading:10393680-Dinoprostone,
pubmed-meshheading:10393680-Disease Progression,
pubmed-meshheading:10393680-Female,
pubmed-meshheading:10393680-Humans,
pubmed-meshheading:10393680-Indomethacin,
pubmed-meshheading:10393680-Infant,
pubmed-meshheading:10393680-Inflammation,
pubmed-meshheading:10393680-Interleukin-6,
pubmed-meshheading:10393680-Isoenzymes,
pubmed-meshheading:10393680-Macrophages,
pubmed-meshheading:10393680-Male,
pubmed-meshheading:10393680-Membrane Proteins,
pubmed-meshheading:10393680-Middle Aged,
pubmed-meshheading:10393680-Muscle, Smooth, Vascular,
pubmed-meshheading:10393680-Prostaglandin-Endoperoxide Synthases,
pubmed-meshheading:10393680-Tunica Media
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms.
|
|
pubmed:affiliation |
Department of Vascular Surgery at Charing Cross and the Department of Clinical Pharmacology at Hammersmith Imperial College School of Medicine (G.W.T.), London, UK.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
